Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rijken

Showing results (111-120 of 810) with videos related to

Pageof 81
Sort By:
Early Human Development|December 5, 2006
The effect of perinatal risk factors on growth in very preterm infants at 2 years of age: the Leiden Follow-Up Project on PrematurityMonique Rijken, Jan M Wit, Saskia Le Cessie, et al.
The British Journal of Dermatology|February 25, 2005
Skin-infiltrating neutrophils following exposure to solar-simulated radiation could play an important role in photoageing of human skinF Rijken, R C M Kiekens, P L B Bruijnzeel
BMC Health Services Research|May 17, 2011
Regulated competition in health care: switching and barriers to switching in the Dutch health insurance systemMargreet Reitsma-van Rooijen, Judith D de Jong, Mieke Rijken
Thrombosis and Haemostasis|April 1, 1997
Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activatorM Barrett-Bergshoeff, F Noorman, R Bos, et al.
Thrombosis and Haemostasis|June 1, 1996
A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluidsE A Braat, U Nauland, G Dooijewaard, et al.
Patient Education and Counseling|December 20, 2011
Attitudes and dilemmas of caregivers supporting people with intellectual disabilities who have diabetesMieke Cardol, Mieke Rijken, Henny van Schrojenstein Lantman-de Valk
Thrombosis and Haemostasis|November 15, 1993
Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strengthD C Rijken, G A de Munk, A F Jie
Journal of Applied Clinical Medical Physics|June 24, 2018
A simple method to account for skin dose enhancement during treatment planning of VMAT treatments of patients in contact with immobilization equipmentJames Rijken, Tanya Kairn, Scott Crowe, et al.
Biochimica Et Biophysica Acta|September 29, 1979
Purification and partial characterization of plasminogen activator from human uterine tissueD C Rijken, G Wijngaards, M Zaal-de Jong, et al.
Microvascular Research|September 1, 1995
Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenograftsP F Rijken, H J Bernsen, A J van der Kogel
Pageof 81

Showing results (111-120 of 810) with videos related to

Sort By:
Pageof 81
Early Human Development|December 5, 2006
The effect of perinatal risk factors on growth in very preterm infants at 2 years of age: the Leiden Follow-Up Project on PrematurityMonique Rijken, Jan M Wit, Saskia Le Cessie, et al.
The British Journal of Dermatology|February 25, 2005
Skin-infiltrating neutrophils following exposure to solar-simulated radiation could play an important role in photoageing of human skinF Rijken, R C M Kiekens, P L B Bruijnzeel
BMC Health Services Research|May 17, 2011
Regulated competition in health care: switching and barriers to switching in the Dutch health insurance systemMargreet Reitsma-van Rooijen, Judith D de Jong, Mieke Rijken
Thrombosis and Haemostasis|April 1, 1997
Monoclonal antibodies against the human mannose receptor that inhibit the binding of tissue-type plasminogen activatorM Barrett-Bergshoeff, F Noorman, R Bos, et al.
Thrombosis and Haemostasis|June 1, 1996
A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluidsE A Braat, U Nauland, G Dooijewaard, et al.
Patient Education and Counseling|December 20, 2011
Attitudes and dilemmas of caregivers supporting people with intellectual disabilities who have diabetesMieke Cardol, Mieke Rijken, Henny van Schrojenstein Lantman-de Valk
Thrombosis and Haemostasis|November 15, 1993
Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strengthD C Rijken, G A de Munk, A F Jie
Journal of Applied Clinical Medical Physics|June 24, 2018
A simple method to account for skin dose enhancement during treatment planning of VMAT treatments of patients in contact with immobilization equipmentJames Rijken, Tanya Kairn, Scott Crowe, et al.
Biochimica Et Biophysica Acta|September 29, 1979
Purification and partial characterization of plasminogen activator from human uterine tissueD C Rijken, G Wijngaards, M Zaal-de Jong, et al.
Microvascular Research|September 1, 1995
Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenograftsP F Rijken, H J Bernsen, A J van der Kogel
Pageof 81